文献速递白血病淋巴瘤

儿童急性白血病伴KMT2A(MLL)重排患者显示独特的组蛋白去乙酰化酶表达模式

Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases.
PubMed 文献 · Br J Haematol · 2018-07-05

该研究分析了211例儿童急性白血病患者中HDAC1-11、SIRT1、SIRT7、MEF2C和MEF2D的mRNA表达,发现HDACs整体过表达,特定HDAC与临床生物学特征相关并可预测结局。KMT2A(MLL)重排患者具有高HDAC9和MEF2D表达的独特特征,且HDAC9过表达与不良预后相关,支持对选定患儿靶向使用特定HDACi。

要点

  • 儿童急性白血病存在HDACs整体过表达,特定HDAC与临床生物学特征相关。
  • KMT2A(MLL)重排患者高表达HDAC9和MEF2D,与年龄、伙伴基因和 lineage 无关。
  • HDAC9过表达与不良预后相关,且不依赖KMT2A重排状态。

核心结论

  • 儿童急性白血病中HDACs整体过表达,特定HDAC和MEF2C谱可能反映白血病细胞的 lineage 和成熟度,并识别活跃的致癌通路。
  • KMT2A(MLL)重排患者具有高HDAC9和MEF2D表达的独特特征,且HDAC9过表达与不良预后相关,支持对选定患儿靶向使用特定HDACi。

研究设计与样本

  • 研究分析了211例儿童急性白血病患者中HDAC1-11、SIRT1、SIRT7、MEF2C和MEF2D的mRNA表达。

主要发现

  • 儿童急性白血病存在HDACs整体过表达,特定HDAC与临床和生物学特征相关,部分甚至可预测结局。
  • KMT2A(MLL)重排患者具有高HDAC9和MEF2D表达的独特特征,与年龄、KMT2A伙伴基因和 lineage 无关。
  • HDAC9过表达与不良预后相关,且不依赖KMT2A重排状态。

临床怎么用

  • 作者认为结果支持对选定的儿童急性白血病患者靶向使用特定HDACi。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Histone deacetylase inhibitors (HDACi) had emerged as promising drugs in leukaemia, but their toxicity due to lack of specificity limited their use. Therefore, there is a need to elucidate the role of HDACs in specific settings. The study of HDAC expression in childhood leukaemia could help to choose more specific HDACi for selected candidates in a personalized approach. We analysed HDAC1-11, SIRT1, SIRT7, MEF2C and MEF2D mRNA expression in 211 paediatric patients diagnosed with acute leukaemia. There was a global overexpression of HDACs, while specific HDACs correlated with clinical and biological features, and some even predicted outcome. Thus, some HDAC and MEF2C profiles probably reflected the lineage and the maturation of the blasts and some profiles identified specific oncogenic pathways active in the leukaemic cells. Specifically, we identified a distinctive signature for patients with KMT2A (MLL) rearrangement, with high HDAC9 and MEF2D expression, regardless of age, KMT2A partner and lineage. Moreover, we observed an adverse prognostic value of HDAC9 overexpression, regardless of KMT2A rearrangement. Our results provide useful knowledge on the complex picture of HDAC expression in childhood leukaemia and support the directed use of specific HDACi to selected paediatric patients with acute leukaemia.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Vega-García N, Malatesta R, Estella C, et al. Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases. Br J Haematol. 2018. PMID: 29978456. doi:10.1111/bjh.15436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。